An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study
Clinical trial NCT01090414 · TERMINATED
Trial details
- NCT number
- NCT01090414
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-22
- Primary completion
- 2018-06-18
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.